Research advances in nonalcoholic fatty liver disease in individuals with HIV infection
10.3969/j.issn.1001-5256.2023.06.030
- VernacularTitle:HIV感染者非酒精性脂肪性肝病的临床研究进展
- Author:
Jiajun LU
1
;
Fazhu FEI
1
;
Bin REN
1
Author Information
1. Qinghai Province Key Laboratory of Hydatid Disease Research, Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qinghai University, Xining 810001, China
- Publication Type:Review
- Keywords:
HIV;
Non-alcoholic Fatty Liver Disease;
Clinical Studies
- From:
Journal of Clinical Hepatology
2023;39(6):1446-1453
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence rate of nonalcoholic fatty liver disease (NAFLD) tends to increase in the general population around the world, and the incidence rate of liver malignancies caused by NAFLD is also increasing continuously. Obesity is an independent risk factor for NAFLD. Among the individuals with HIV infection who have a normal body weight, 25% have NAFLD, and lean NAFLD is relatively common in individuals with HIV infection. With reference to related articles in China and globally, this article reviews the epidemiology, pathophysiology, histology, diagnosis, screening, intervention, treatment, and clinical management of NAFLD, in order to improve the awareness of NAFLD in individuals with HIV infection among the public, clinicians, and related institutions.
